Welcome to the December, 2008 issue of Pharma Marketing News.
To better understand the impact of this code on the pharmaceutical industry, Pharma Marketing News surveyed readers between July 10, 2008 and August 7, 2008, and collected comments from pharma-focused blogs and bulletin boards. This article is a summary of the PMN survey results and opinions of experts, bloggers, and anonymous commentators.
This article, written by a marketer with firsthand experience, provides an overview of the pharmaceutical markets and promotional practices in India.
Medical journals may soon become the pharmaceutical industry's newest physician marketing partner. This article summarizes some of the pros and cons of FDA's Good Reprint Practices Guidance and presents preliminary results of a reader survey on the topic.
Welcome to the June/July, 2008 issue of Pharma Marketing News.
Possibly the most important political change facing the pharmaceutical industry in 2006 is who will be the new FDA Commissioner. Various stakeholders -- including executives and staffers working within the pharmaceutical industry, agents and vendors to the industry, healthcare professionals, members of the general public, and staffers within government health agencies -- have divergent opinions on who should be the commissioner and why. This article summarizes the results of a recent survey of such stakeholders.
Welcome to the October, 2008 issue of Pharma Marketing News.
Healthcare marketers are rewarded for increasing product revenue. However, product managers often miss a golden opportunity to drive product sales: they neglect to communicate clinical trial results properly and consequently fail to capitalize on completed medical research.This article highlights how to effectively communicate scientific evidence in order to realize the full medical and commercial value of your brand and to maximize sales.
Welcome to the January, 2008 issue of Pharma Marketing News.
As everyone knows by now, Pfizer caved in to withering criticism from Congress and the Pharma BlogospereT and pulled the Jarvik Lipitor ads. 'Oh what a tangled web we weave, When first we practise to deceive!'